Ballweg Matthew, Ortmann Laura A
Department of Surgery (MB), University of Nebraska Medical Center, Department of Pediatrics, University of Nebraska Medical Center (LAO), Omaha, NE.
J Pediatr Pharmacol Ther. 2025 Feb;30(1):93-99. doi: 10.5863/1551-6776-30.1.93. Epub 2025 Feb 10.
Hypochloremia is common in children receiving diuretics and may contribute to diuretic -resistance. This study's objective was to investigate whether arginine hydrochloride supplementation for -hypochloremia was associated with a change in urine output (UOP) or fluid balance (FB) in children -receiving diuretics.
This was an observational retrospective study of children admitted to the pediatric, cardiac, or neonatal intensive care unit. Patients were included if they received at least 3 days of loop or thiazide diuretics then supplemented with arginine hydrochloride during ongoing diuresis. Data collected included diagnosis category, electrolyte supplementation and serum concentrations, weights, and all fluid input and output. UOP and FB were compared in the 48 hours before and after supplementation.
Of the 345 children studied, 60% had underlying cardiac disease and 97% received furosemide. Median arginine hydrochloride dose was 0.9 mEq/kg, most often given every 6 hours for 4 doses. Serum chloride concentrations rose from 91.6 to 96.4 mmol/L (p < 0.001). There was no difference in UOP (4.6 vs 4.4 mL/kg/hr, p = 0.06) or FB (1.5 vs 2.7 mL/kg/day, p = 0.13) when comparing the 48 hours before supplementation with the 48 hours after. Analyses of patients with stable diuretic dosing, those with a serum chloride concentration ≤90 mmol/L, those with an increase in serum chloride ≥8 mmol/L, and those with cardiac disease had no improvement in UOP or FB after chloride supplementation.
Arginine hydrochloride supplementation was not associated with an improvement in diuretic effectiveness in children as demonstrated by lack of improvement in UOP or FB.
低氯血症在接受利尿剂治疗的儿童中很常见,可能导致利尿剂抵抗。本研究的目的是调查补充盐酸精氨酸治疗低氯血症是否会使接受利尿剂治疗的儿童尿量(UOP)或液体平衡(FB)发生变化。
这是一项对入住儿科、心脏科或新生儿重症监护病房儿童的观察性回顾性研究。纳入的患者需接受至少3天的袢利尿剂或噻嗪类利尿剂治疗,且在持续利尿期间补充盐酸精氨酸。收集的数据包括诊断类别、电解质补充及血清浓度、体重以及所有的液体出入量。比较补充前48小时和补充后48小时的UOP和FB。
在研究的345名儿童中,60%有潜在心脏病,97%接受了呋塞米治疗。盐酸精氨酸的中位剂量为0.9 mEq/kg,最常每6小时给药1次,共4次。血清氯浓度从91.6 mmol/L升至96.4 mmol/L(p<0.001)。比较补充前48小时和补充后48小时,UOP(4.6 vs 4.4 mL/kg/小时,p = 0.06)或FB(1.5 vs 2.7 mL/kg/天,p = 0.13)无差异。对利尿剂剂量稳定的患者、血清氯浓度≤90 mmol/L的患者、血清氯升高≥8 mmol/L的患者以及有心脏病的患者进行分析,补充氯后UOP或FB均未改善。
补充盐酸精氨酸并未改善儿童利尿剂的疗效,这表现为UOP或FB未得到改善。